Wolverine Asset Management’s CONMED CNMD Stock Holding History

Wolverine Asset Management’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-6,030	Closed	-$787K	–	2194
2021 Q1	$787K	Buy	+6,030	New	+$726K	0.01%	733
2019 Q4	–	Sell	-11,797	Closed	-$1.13M	–	1384
2019 Q3	$1.13M	Buy	+11,797	New	+$1.11M	0.01%	569

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Wolverine Asset Management's CNMD Position: Q2 2021 in Review

Wolverine Asset Management sold out of CONMED (CNMD) in Q2 2021, closing a stake of 6,030 shares — an estimated $787K sold.

Wolverine Asset Management first reported a position in CNMD in Q3 2019 and held it in 2 quarters. The position peaked at $1.13M in Q3 2019. 252 funds tracked by Wall St. Rank hold CNMD as of Q2 2021.

Wolverine Asset Management reported no remaining CONMED position as of Q2 2021 after selling out during the quarter.
Wolverine Asset Management sold 6,030 CONMED shares in Q2 2021, an estimated $787K.
Wolverine Asset Management first reported a position in CONMED in Q3 2019 and held it in 2 quarters.
Wolverine Asset Management's CONMED position peaked at $1.13M in Q3 2019.
252 funds tracked by Wall St. Rank held CONMED as of Q2 2021.

Based on Wolverine Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.